Home / Inspections / 1257794

FDA Inspection 1257794 — Center for Reproductive Health and Gynecology

Center for Reproductive Health and Gynecology — FEI 3004627513

The FDA completed an inspection of Center for Reproductive Health and Gynecology on December 17, 2024 in Beverly Hills, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
December 17, 2024
Fiscal Year
2025
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Beverly Hills, CA (United States)

Facility

Other inspections at this facility

  • 1086927 (NAI Thu Apr 04 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 986031 (NAI Wed Sep 28 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 808764 (NAI Fri Nov 30 2012 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 682976 (NAI Fri Sep 24 2010 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources